Search research articles
Contact Us
Filters
Showing results (51-60 of 100) with videos related to
Page
of 10
Sort By:
Drug Safety
|
August 16, 2017
Deaths from Medicines: A Systematic Analysis of Coroners' Reports to Prevent Future Deaths
Robin E Ferner, Craig Easton, Anthony R Cox
British Journal of Clinical Pharmacology
|
July 17, 2023
Drug shortages. Part 1. Definitions and harms
Jeffrey K Aronson, Carl Heneghan, Robin E Ferner
Drug Safety
|
November 18, 2009
Improving follow-up rates in spontaneous adverse drug reaction reporting: effectiveness of a targeted letter used by a regional centre in the UK
Christopher Anton, Anthony R Cox, Robin E Ferner
Drug Safety
|
February 17, 2016
Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP)
Manfred Hauben, Jeffrey K Aronson, Robin E Ferner
BMJ (Clinical Research Ed.)
|
July 26, 2018
Prescribing biosimilars
Jeffrey K Aronson, Ben Goldacre, Robin E Ferner
Drug Safety
|
February 25, 2009
A strategy for regulatory action when new adverse effects of a licensed product emerge
Jeffrey K Aronson, Deirdre Price, Robin E Ferner
BMJ Evidence-Based Medicine
|
December 22, 2021
Deaths attributed to the use of medications purchased online
Jeffrey K Aronson, Robin E Ferner, Georgia C Richards
British Journal of Clinical Pharmacology
|
July 15, 2009
The pathophysiology of medication errors: how and where they arise
Sarah E McDowell, Harriet S Ferner, Robin E Ferner
Drug Safety
|
June 28, 2012
Dose omissions in hospitalized patients in a UK hospital: an analysis of the relative contribution of adverse drug reactions
Jamie J Coleman, Sarah E McDowell, Robin E Ferner
BMJ (Clinical Research Ed.)
|
January 7, 2010
NICE and new: appraising innovation
Robin E Ferner, Dyfrig A Hughes, Jeffrey K Aronson
Page
of 10
Search research articles
Search
Showing results (51-60 of 100) with videos related to
Sort By:
Page
of 10
Drug Safety
|
August 16, 2017
Deaths from Medicines: A Systematic Analysis of Coroners' Reports to Prevent Future Deaths
Robin E Ferner, Craig Easton, Anthony R Cox
British Journal of Clinical Pharmacology
|
July 17, 2023
Drug shortages. Part 1. Definitions and harms
Jeffrey K Aronson, Carl Heneghan, Robin E Ferner
Drug Safety
|
November 18, 2009
Improving follow-up rates in spontaneous adverse drug reaction reporting: effectiveness of a targeted letter used by a regional centre in the UK
Christopher Anton, Anthony R Cox, Robin E Ferner
Drug Safety
|
February 17, 2016
Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP)
Manfred Hauben, Jeffrey K Aronson, Robin E Ferner
BMJ (Clinical Research Ed.)
|
July 26, 2018
Prescribing biosimilars
Jeffrey K Aronson, Ben Goldacre, Robin E Ferner
Drug Safety
|
February 25, 2009
A strategy for regulatory action when new adverse effects of a licensed product emerge
Jeffrey K Aronson, Deirdre Price, Robin E Ferner
BMJ Evidence-Based Medicine
|
December 22, 2021
Deaths attributed to the use of medications purchased online
Jeffrey K Aronson, Robin E Ferner, Georgia C Richards
British Journal of Clinical Pharmacology
|
July 15, 2009
The pathophysiology of medication errors: how and where they arise
Sarah E McDowell, Harriet S Ferner, Robin E Ferner
Drug Safety
|
June 28, 2012
Dose omissions in hospitalized patients in a UK hospital: an analysis of the relative contribution of adverse drug reactions
Jamie J Coleman, Sarah E McDowell, Robin E Ferner
BMJ (Clinical Research Ed.)
|
January 7, 2010
NICE and new: appraising innovation
Robin E Ferner, Dyfrig A Hughes, Jeffrey K Aronson
Page
of 10